For children with Graves' disease who did not improve with medication, removing the entire thyroid gland is associated with a higher chance of permanently curing the overactive thyroid condition compared to treatment with radioactive iodine.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of randomized controlled trials would definitively establish whether thyroidectomy causes higher cure rates than radioactive iodine by eliminating selection bias.
A systematic review and meta-analysis of all published and unpublished randomized controlled trials comparing total thyroidectomy versus radioactive iodine (150–200 mCi) in children aged 8–18 with Graves' disease refractory to at least 12 months of antithyroid medication, with cure defined as sustained euthyroidism without medication at 5 years, and outcomes assessed by blinded endocrinologists using standardized thyroid function tests and antibody titers.
A randomized controlled trial would determine whether thyroidectomy causally leads to higher cure rates than radioactive iodine by eliminating confounding from physician or family preference.
A multicenter, double-blind, placebo-controlled RCT enrolling 300 children aged 8–18 with Graves' disease failing 12 months of antithyroid medication, randomized 1:1 to total thyroidectomy or radioactive iodine (150 mCi), with primary outcome: sustained euthyroidism at 5 years without medication, secondary outcomes: hypothyroidism, hypoparathyroidism, vocal cord function, and quality of life, assessed by blinded endocrinologists and pediatricians.
A prospective cohort study with standardized treatment allocation and long-term follow-up could strengthen the observed association by reducing recall and selection bias present in retrospective studies.
A prospective multicenter cohort study following 500 children aged 8–18 with Graves' disease failing medical therapy, prospectively assigned to thyroidectomy or radioactive iodine based on standardized clinical criteria, with blinded outcome assessment of cure, hypothyroidism, and complications at 1, 3, and 5 years, adjusting for baseline TSH, TRAb, and socioeconomic factors.
A case-control study could identify whether children who achieved cure after thyroidectomy differ systematically from those who relapsed after RAI in terms of baseline characteristics or treatment timing.
A matched case-control study comparing 200 children cured after thyroidectomy with 200 children who relapsed after RAI, matched for age, sex, baseline TSH, TRAb, and duration of medical therapy, assessing differences in treatment timing, surgeon volume, iodine exposure, and genetic markers.
A cross-sectional study could estimate the prevalence of cure or hypothyroidism at a single time point across different treatment groups, but cannot determine causality or long-term outcomes.
A national cross-sectional survey of 1,000 children aged 8–18 with a history of Graves' disease treated with either thyroidectomy or radioactive iodine, assessing current thyroid status, medication use, and complications at a single time point, stratified by treatment type and time since intervention.